Induction EGFR tyrosine kinase inhibitors prior to definitive chemoradiotherapy in unresectable stage III EGFR-mutated non-small cell lung cancer
- Jacqueline V. Aredo
- , Heather A. Wakelee
- , Angela Bik Yu Hui
- , Sukhmani K. Padda
- , Nitin D. Joshi
- , H. Henry Guo
- , Aadel Chaudhuri
- , Maximilian Diehn
- , Billy W. Loo
- , Joel W. Neal
- University of California at San Francisco
- Stanford University
- Cedars-Sinai Medical Center
- Washington University St. Louis
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations